Nusayba Bagegni, MD

Financial relationships

  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    OncLive/MJH Life Sciences
    Topic: 
    Current and Emerging Trends in Breast Cancer: HER2- Positive and HER-Low: An OncLive Scientific Interchange and Workshop
    Date added: 
    02/21/2023
    Relationship end date: 
    12/14/2021
  • Attribution: 
    Self
    Type of financial relationship: 
    Professional Services
    Ineligible company: 
    Total Health Conferencing
    Topic: 
    New and supporting data for optimizing Therapy in HER2 positive breast cancer.
    Date added: 
    02/21/2023
    Relationship end date: 
    06/27/2021
Return to 2023 BTF Multidisciplinary Breast Cancer Conference